Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jonathan C. Oh"'
Autor:
Minal A. Barve, Devansu Tewari, Rodney P. Rocconi, Justin Bottsford-Miller, Gladice Wallraven, Laura Stanbery, John Nemunaitis, Bradley J. Monk, Brian M. Slomovitz, Peter C. Morris, Robert L. Coleman, Thomas J. Herzog, Phylicia Aaron, David M. Shanahan, Jonathan C. Oh, Erin E. Stevens, Elizabeth A. Grosen, John K. Chan, Staci Horvath, Sharad A. Ghamande, Luisa Manning, Ernest Bognar, Min Tang
Publikováno v:
The Lancet Oncology. 21:1661-1672
Summary Background Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-β1 and TGF-β2. The aim of this study was to determine the safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f8cb1c5ab1c279408411411ca87bc5
https://doi.org/10.1016/s1470-2045(20)30533-7
https://doi.org/10.1016/s1470-2045(20)30533-7
Autor:
Kathleen M. Schmeler, Brian M. Slomovitz, David M. Gershenson, Charlotte C. Sun, Pamela T. Soliman, Thomas W. Burke, Karen H. Lu, Jonathan C. Oh
Publikováno v:
Obstetrics & Gynecology. 105:575-580
Endometrial cancer is the most common gynecologic malignancy in the United States. The mean age at diagnosis is 61 years; however, 5-30% of women are aged younger than 50 years at the time of diagnosis. The objective of this study was to conduct a cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c4ef2163e5d4e0353f764a936913f8
https://doi.org/10.1097/01.aog.0000154151.14516.f7
https://doi.org/10.1097/01.aog.0000154151.14516.f7
Autor:
Jonathan C. Oh, Sergio Martínez-Román, Homer A. Macapinlac, Marcelo Gonzalez Viciedo, Pedro T. Ramirez
Publikováno v:
Gynecologic Oncology. 96:888-891
Background The role of combined positron emission tomography and computed tomography (PET-CT) in the diagnosis of recurrent ovarian mucinous adenocarcinoma is uncertain because of previous reports that PET has limited sensitivity in the detection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7c9349a60781198b50df1595832358
https://doi.org/10.1016/j.ygyno.2004.10.045
https://doi.org/10.1016/j.ygyno.2004.10.045
Autor:
David M. Gershenson, Patricia J. Eifel, Charlotte C. Sun, Pamela T. Soliman, Brian M. Slomovitz, Russell Broaddus, Karen H. Lu, Jonathan C. Oh
Publikováno v:
Gynecologic Oncology. 94:456-462
Objectives . Synchronous primary cancers of the endometrium and ovary are found in 10% of women with ovarian cancer and 5% of women with endometrial cancer. The purpose of this study was to characterize patients diagnosed with synchronous primary can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dbe047724a2c74b41cb6a40c93fce23
https://doi.org/10.1016/j.ygyno.2004.05.006
https://doi.org/10.1016/j.ygyno.2004.05.006
Publikováno v:
International Journal of Gynecological Cancer. 14:621-624
The rate of groin breakdown after radical wide vulvar excision and inguinal lymphadenectomy for vulvar cancer remains significant despite conservative surgical approaches. An 86-year-old Latin American woman underwent wide radical excision and bilate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d61a63a032acc0aeb0ec1a6c397081b
https://doi.org/10.1111/j.1048-891x.2004.14411.x
https://doi.org/10.1111/j.1048-891x.2004.14411.x
Autor:
Jonathan C. Oh, Weiguo Wu, Guillermo Tortolero-Luna, Russell Broaddus, David M. Gershenson, Thomas W. Burke, Rosemarie Schmandt, Karen H. Lu
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 13:748-752
Circulating insulin-like growth factors (IGFs) and their binding proteins have been associated with increased risk of breast, prostate, colon, and lung cancer. To examine the association of IGFs and endometrial cancer risk, we measured the plasma lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f21692df47745d5a1324f0834ecf9687
https://doi.org/10.1158/1055-9965.748.13.5
https://doi.org/10.1158/1055-9965.748.13.5
Autor:
Thomas W. Burke, Anuja Jhingran, Lois M. Ramondetta, Jonathan C. Oh, Patricia J. Eifel, David M. Gershenson, Brian M. Slomovitz, Christine M. Lee, Karen H. Lu
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 15(3)
The purpose of this study was to evaluate overall survival (OS) and determine prognostic subclassifications for stage IIIA endometrial cancer. Stage IIIA endometrial cancer patients treated at M.D. Anderson Cancer Center from 1989 to 2002 were review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0c53787bc3e196c673599d71b39d3f
https://pubmed.ncbi.nlm.nih.gov/15882178
https://pubmed.ncbi.nlm.nih.gov/15882178
Autor:
Jonathan C, Oh, Weiguo, Wu, Guillermo, Tortolero-Luna, Russell, Broaddus, David M, Gershenson, Thomas W, Burke, Rosemarie, Schmandt, Karen H, Lu
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 13(5)
Circulating insulin-like growth factors (IGFs) and their binding proteins have been associated with increased risk of breast, prostate, colon, and lung cancer. To examine the association of IGFs and endometrial cancer risk, we measured the plasma lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8071e7ec136944170ca6add63092fdd8
https://pubmed.ncbi.nlm.nih.gov/15159305
https://pubmed.ncbi.nlm.nih.gov/15159305
Autor:
Anuja Jhingran, Elvio G. Silva, Brian M. Slomovitz, Russell Broaddus, E. Neely Atkinson, David M. Gershenson, Thomas W. Burke, Karen H. Lu, Jonathan C. Oh, Patricia J. Eifel, Lois M. Ramondetta
Publikováno v:
Gynecologic oncology. 91(3)
Objective The aim of this study was to identify clinical and pathologic characteristics of patients with uterine papillary serous carcinoma (UPSC) who were all surgically managed at a single institution. The identified characteristics were then corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a413b8d2766eecd49095c664212c4af3
https://pubmed.ncbi.nlm.nih.gov/14675662
https://pubmed.ncbi.nlm.nih.gov/14675662
Autor:
David M. Gershenson, Thomas W. Burke, Rosemarie Schmandt, Weiguo Wu, Brian M. Slomovitz, Jonathan C. Oh, Russell Broaddus, Lois M. Ramondetta, Karen H. Lu
Publikováno v:
Gynecologic oncology. 95(1)
Purpose. Imatinib mesylate is a tyrosine kinase inhibitor that specifically targets c-Kit, Abl, and platelet-derived growth factor receptor (PDGFR). It has been shown to be an effective treatment for patients with chronic myelogenous leukemia (CML) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6cf08f31c64acb31bbce836a23e943
https://pubmed.ncbi.nlm.nih.gov/15385107
https://pubmed.ncbi.nlm.nih.gov/15385107